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Introduction
Centrosomes are the main microtubule-organizing centers 
(MTOCs) of most animal cells and are composed of a pair of 
centrioles surrounded by pericentriolar material (PCM; Nigg 
and Raff, 2009; Gönczy, 2012). Centrioles act as the centro-
some organizer and thus their duplication controls centrosome 
number. Like DNA, centrioles duplicate exactly once per cell 
cycle, with a single new procentriole forming on the wall of 
each existing centriole (Tsou and Stearns, 2006). This tightly 
controlled process ensures the generation of two centrosomes 
to form the poles of the bipolar mitotic spindle. Errors in centri-
ole duplication lead to abnormal centrosome number, which can 
result in chromosome segregation errors and the production of 
aneuploid progeny (Ganem et al., 2009; Silkworth et al., 2009). 
Aberrations in centrosome number have been associated with 
several human diseases, including cancer and neurodevelop-
mental disorders (Nigg and Raff, 2009).
Canonical centriole duplication begins at the G1/S tran-
sition with the assembly of a single cartwheel structure on the 
wall of each preexisting mother centriole. The cartwheel then 
templates the formation of a procentriole by providing a scaf-
fold onto which microtubules are loaded (Kitagawa et al., 2011; 
van Breugel et al., 2011, 2014). In addition to this canonical 
pathway of centriole assembly, de novo centriole formation 
can occur in the absence of existing centrioles (Miki-Noumura, 
1977; Szöllosi and Ozil, 1991; Palazzo et al., 1992; Marshall et 
al., 2001; Suh et al., 2002). A striking example of this process 
occurs in mouse embryos, where cell divisions continue in the 
absence of centrioles until the 64-cell stage, at which point cen-
trioles are created de novo (Szollosi et al., 1972). In vertebrate 
somatic cells, a variable number of de novo centrioles are gen-
erated after experimental removal of existing centrioles (Khod-
jakov et al., 2002; La Terra et al., 2005; Uetake et al., 2007). It 
is therefore thought that existing centrioles act to suppress de 
novo centriole assembly, although the molecular mechanism for 
this suppression remains unclear.
Previous approaches to study the immediate consequence 
of centriole loss in human cells have relied on laser ablation 
or microsurgery (Khodjakov et al., 2002; La Terra et al., 2005; 
Uetake et al., 2007). These elegant approaches only transiently 
remove centrioles from a small number of cells. Permanent 
centriole loss has been achieved through the knockout of es-
sential centriole components (Sir et al., 2013; Bazzi and An-
derson, 2014; Izquierdo et al., 2014). Although informative, 
these studies did not address the immediate effects of centri-
ole duplication failure and were unable to temporally control 
formation of new centrioles.
Polo-like kinase 4 (Plk4) has emerged as a conserved, 
dose-dependent regulator of centriole copy number and offers 
an attractive target to reversibly modulate centriole number in 
populations of cells (Bettencourt-Dias et al., 2005; Habedanck 
et al., 2005). Plk4 is a self-regulating enzyme that phosphory-
lates itself to promote its own destruction (Cunha-Ferreira et 
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al., 2009, 2013; Rogers et al., 2009; Guderian et al., 2010; Hol-
land et al., 2010; Brownlee et al., 2011; Klebba et al., 2013). 
This autoregulated destruction plays an important role in con-
trolling the abundance of endogenous Plk4 and thereby helps to 
limit centriole duplication to once per cell cycle (Holland et al., 
2012b). RNA interference and knock-in approaches have been 
used to inhibit Plk4 function, but these strategies are slow acting 
and are not readily reversible. Inhibition of Plk4 kinase activity 
offers a powerful alternative to manipulate Plk4 function. How-
ever, specific kinase inhibitors are difficult to develop (Holland 
and Cleveland, 2014; Mason et al., 2014). In addition, inhibit-
ing Plk4 activity greatly increases protein abundance, making it 
challenging to dissect the relative contribution of loss of kinase 
activity and increased protein abundance (Holland et al., 2010).
In this study, we developed a chemical genetics approach 
to rapidly and reversibly control Plk4 protein abundance in 
cells. Manipulating endogenous Plk4 levels allowed the re-
versible depletion of centrioles from populations of cycling 
cells and uncovered the existence of a p53-dependent pathway 
that guards against genome instability by preventing cellu-
lar proliferation after centriole duplication failure. By taking 
advantage of the acute and titratable depletion of Plk4, our 
data define the threshold level of Plk4 required for centriole 
assembly and establish the consequence of acute Plk4 deple-
tion on centriole composition.
Results
A novel system for rapidly and reversibly 
controlling Plk4 levels
To study the immediate effects caused by Plk4 depletion, we 
turned to an auxin-inducible degradation system that allows for 
posttranslational control of protein abundance with the plant hor-
mone auxin (Nishimura et al., 2009). In plants, auxin promotes 
the binding of the F-box protein osTIR1 to proteins contain-
ing an auxin-inducible degron (AID). In the presence of auxin, 
osTIR1 recruits AID-containing substrates to the Skp1, Cullin, 
and F-Box ubiquitin ligase, which ubiquitinates the AID-con-
taining protein and targets it for proteasomal degradation. Ec-
topic expression of osTIR1 in mammalian cells generates an 
SCFTIR1 complex and enables auxin-inducible destruction of 
AID-tagged transgenes (Holland et al., 2012a), suggesting that 
the AID system could also be applied to posttranslationally reg-
ulate the stability and abundance of endogenous Plk4.
We used sequential rounds of gene targeting to knock-in 
the AID onto the C terminus of both endogenous Plk4 alleles in 
nontransformed, telomerase-immortalized, human RPE-1 cells 
(Fig. S1, A and B). To facilitate detection, each Plk4AID allele 
was tagged at the C terminus with a HA or 3× FLAG tag. Two 
Plk4AID-HA/AID-3xFLAG (hereafter referred to as Plk4AID/AID) clones 
were obtained and behaved similarly in all assays. Plk4AID/AID 
cells exhibited normal centrosome copy number and cell cycle 
profiles (Fig. S1, C and D), and both Plk4AID-HA and Plk4AID-FLAG 
localized to the centrioles of cells in interphase and mitosis in 
a manner that was indistinguishable from wild-type Plk4 (Fig. 
S1 E). We conclude that Plk4AID is capable of supporting Plk4 
function in centriole duplication.
We stably expressed osTIR1-9xMyc in Plk4AID/AID cells 
to place the stability of endogenous Plk4AID under the control 
of exogenous auxin (Fig. 1 A). To analyze Plk4 protein levels, 
we immunoprecipitated Plk4AID-3xFLAG from cell lysates using a 
FLAG antibody and determined the abundance of Plk4 by im-
munoblot. Addition of the auxin indole-3-acetic acid (IAA) to 
Plk4AID/AID cells led to rapid Plk4 degradation, with Plk4 fall-
ing below the limit of detection within 10 min of IAA addition 
(Fig. 1 B). The level of Plk4 at the centrosome was measured 
at various times after IAA addition using antibodies raised to 
the FLAG tag or to the C terminus of Plk4. Staining with the 
monoclonal FLAG antibody revealed that the level of Plk4 at 
the centrosomes of interphase cells declined by >95% within 
30 min of IAA addition (Fig. 1, C and D), whereas staining 
with a polyclonal antibody to the C terminus of Plk4 revealed a 
>80% reduction during the same time period (Fig. S1 F). Plk4 
destruction occurred in all cell cycle phases (Fig. 1 E) and re-
quired the presence of the osTIR1 F-box protein (Fig. S1 G). 
Importantly, the degradation of Plk4 was fully reversible, with 
the level of Plk4 at the centriole recovering to original levels 
within 3 h of IAA removal (Fig. 1 F).
To examine whether treatment with IAA leads to the ex-
pected failure of centriole duplication, we assessed centriole 
number in cells undergoing mitosis one cell cycle (30 h) after 
IAA addition. In untreated Plk4AID/AID cells, centriole duplica-
tion occurred successfully in >90% of cells (0 µM IAA; Fig. 2, 
A and B). In contrast, IAA addition caused a failure of centriole 
duplication in >90% of Plk4AID/AID cells (500 µM IAA; Fig. 2, 
A and B). We conclude that Plk4AID/AID cells offer a new tool 
to achieve rapid and reversible depletion of endogenous Plk4.
A graded reduction in protein levels reveals 
a threshold level of Plk4 required for 
centriole duplication
Reduced expression of Plk4 has been associated with tumor-
igenesis, but it remains unknown how much Plk4 protein is 
required for centriole duplication (Ko et al., 2005; Pellegrino 
et al., 2010; Liu et al., 2012). Because Plk4 autoregulates its 
own stability, generating a progressive reduction in Plk4 protein 
levels is challenging, as a reduced abundance of Plk4 mRNA 
may not lead to a comparable down-regulation of Plk4 protein 
(Holland et al., 2012a). We therefore set out to use auxin-induc-
ible destruction to generate a graded reduction in Plk4 levels. 
We used quantitative microscopy with directly labeled Plk4 
primary antibodies to determine the abundance of Plk4 at the 
centriole in cells treated with various concentrations of IAA. 
Exposing Plk4AID/AID cells to increasing concentrations of IAA 
resulted in gradual reduction in the average level of Plk4 at the 
centriole (Fig. 2 A). We examined whether centriole duplication 
occurred successfully with different levels of Plk4 protein. In 
cells treated with 1 µM IAA, the average level of Plk4 at the 
centrosome was 81% of that in untreated cells (Fig. 2, A and 
B). Under these conditions, centrioles duplicated in >75% of 
cells. However, at 10 µM IAA, whereas centrosomal Plk4 levels 
were maintained at 57% of that in control cells, <10% of cells 
underwent centriole duplication (Fig. 2, A and B). We conclude 
that Plk4 levels are finely balanced and that a less than twofold 
reduction in the level of Plk4 at the centrosome leads to a fail-
ure of centriole duplication.
The centriole localization of STIL is uniquely 
sensitive to the levels of Plk4
RNA interference of Plk4 leads to slow protein depletion, mak-
ing it challenging to distinguish between direct and indirect ef-
fects of Plk4 removal. The ability to rapidly remove Plk4 from 
cells provided an opportunity to identify proteins that directly 
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depend on Plk4 for recruitment to the centriole. We used im-
munofluorescence microscopy to examine the abundance of 10 
proteins (CPAP, CEP135, CEP152, CEP192, SAS6, CNAP1, 
CEP164, Centrin, γ-tubulin, and STIL) at the centrosome 1 h 
after Plk4 destruction with IAA. Because the abundance of sev-
eral centriole proteins are reduced after mitosis (Strnad et al., 
2007; Tang et al., 2009; Tang et al., 2011; Arquint et al., 2012; 
Arquint and Nigg, 2014), our measurements were made in S/
G2 cells that were marked by the presence of CENP-F (Hussein 
and Taylor, 2002). Of the 10 proteins examined, the localization 
of STIL was uniquely sensitive to a reduction in Plk4 levels: 
the abundance of STIL at the centriole was reduced by >75% 1 
h after IAA addition, whereas total protein levels remained un-
changed (Fig. 2 C). These data are consistent with a recent study 
showing that Plk4 binds to STIL (Ohta et al., 2014). STIL has 
been proposed to recruit SAS6 to the centriole through a direct, 
phosphorylation-dependent interaction (Dzhindzhev et al., 2014; 
Ohta et al., 2014). However, whereas STIL levels declined dra-
matically by 1 h after acute Plk4 destruction, we observed only a 
modest change in centriole SAS6 levels, suggesting STIL is not 
required to maintain existing SAS6 at the centriole (Fig. 2 C).
Cells lacking Plk4 undergo a cell 
cycle arrest
We next examined the chronic effect of Plk4 depletion in RPE1 
cells. Although Plk4+/+ cells proliferated normally in the pres-
ence of IAA, addition of IAA to Plk4AID/AID cells resulted in a 
cell cycle arrest 48 h after treatment began (Fig. 3 A). Interphase 
Plk4AID/AID cells exhibited a dramatic reduction in centriole 
number by 24 h after IAA addition (Fig. 3 B). Centriole number 
decreased further by 48 h after Plk4 degradation, giving rise to 
22% of cells that lack centrioles. After this time, centriole con-
tent changed only slowly, consistent with the fact that the vast 
majority of cells cease proliferating by 48 h after IAA addition.
To evaluate the long-term growth potential of cells that 
lack endogenous Plk4, we performed clonogenic survival as-
Figure 1. Inducible destruction of endogenous Plk4. 
(A) Schematic outlining the strategy for the auxin-in-
ducible destruction of Plk4. (B) Western blot showing 
the levels of immunoprecipitated Plk4-AID-FLAG at 
the indicated times after IAA addition. (C) Plk4AID/
AID cells immunostained for CEP192, Plk4, and FLAG 
after treatment with IAA for the indicated time. Bars: 
(main) 5 µm; (inset) 1 µm. (D) Quantification of the 
level of FLAG-tagged Plk4-AID at the centrosome at 
the indicated times after IAA addition. Each condition 
represents the mean of >70 cells from at least two in-
dependent experiments. (E) Quantification of the level 
of FLAG-tagged Plk4-AID at the centrosome at the indi-
cated cell cycle stages. Horizontal line represents the 
mean of >70 cells from two independent experiments. 
(F) Quantification of Plk4 protein levels at the centro-
some at the indicated time after IAA washout. Plk4 
levels return to normal within 3 h of auxin removal. 
Each bar represents the mean of >70 cells from at 
least two independent experiments. All error bars in 
the figure represent the SEM.
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says. IAA addition prevented colony formation in Plk4AID/AID 
cells, but only modestly affected the survival of Plk4+/+ and 
Plk4+/AID cells (Fig. S2, A and B). To determine whether Plk4 
depletion leads to an irreversible cell cycle arrest, we treated 
Plk4AID/AID cells with IAA for either 1 h or 4 d and then re-
stored Plk4 levels by washing out IAA. Although 1 h of IAA 
treatment had no affect on cell growth, washout of IAA after 
4 d of treatment was unable to restore cell proliferation (Fig. 
3 C). We conclude that chronic depletion of Plk4 leads to an 
irreversible cell cycle arrest.
To examine the effect of centriole loss on cell division, 
we created Plk4AID/AID cells coexpressing TagRFP-tubulin, 
EGFP-Histone H2B, and EGFP-Cep63 (to mark parental centri-
oles; Sir et al., 2011) and monitored cells by time-lapse micros-
copy. Untreated control cells progressed though mitosis with 
a mean time of 44 min and contained a single EGFP-Cep63 
focus at each spindle pole (Fig. 3, D and G; and Video 1). In the 
first 24 h after Plk4 destruction, all cells formed bipolar spin-
dles and divided normally, albeit with a modest mitotic delay 
(mean time of 58 min to divide; Fig. 3, D and E). However, 
by the second day after IAA addition the duration of mitosis 
increased to a mean time of 84 min (Fig. 3 D). Nevertheless, all 
cells progressed to anaphase and successfully executed cytoki-
nesis (Fig. 3 E). Although there was an increase in chromosome 
segregation errors in auxin-treated cells, the frequency of these 
errors was too small to account for the growth arrest (Fig. 3 E). 
Interestingly, in a significant fraction of divisions, multi-lobed 
nuclei formed after apparently normal anaphase chromosome 
movements (Fig. 3, F and G; and Video 2). Importantly, these 
cell division defects were not caused by drug treatment alone, 
as IAA had little effect on mitotic timing or nuclear shape in 
Plk4+/+ RPE1 cells (Fig. S2, C and D).
The cell cycle arrest after centriole 
duplication failure is not caused by a 
prolonged mitosis
Using fixed imaging, we examined the number of centrioles at 
various time points after IAA treatment. As expected, untreated 
control cells divided with two centrioles at each spindle pole 
(Fig. 4, A and B). In contrast, at 1 d after IAA addition, >90% 
of Plk4AID/AID cells divided with a single centriole at each spin-
dle pole, whereas at days 2 and 3 after IAA addition >65% 
of cells divided with an asymmetric spindle comprised of an 
acentriolar pole and a pole containing a single centriole (Fig. 4, 
A and B). Cell divisions were rarely observed to take place in 
the absence of centrioles.
Previous work has shown that prolonging prometaphase 
to >90 min leads to a durable G1 arrest in RPE1 cells (Uetake 
and Sluder, 2010). We therefore investigated whether an in-
creased mitotic duration could account for the cell cycle ar-
rest observed after centriole duplication failure. We first set 
out to determine the window of tolerance for prometaphase 
duration in Plk4AID/AID cells. Plk4AID/AID cells were treated 
with 0.08 µM nocodazole for 6 h and the proliferative fate 
of daughter cells was monitored using time-lapse micros-
copy. Similar to the parental RPE1 cells, prolonging the du-
ration of prometaphase in Plk4AID/AID cells to >97 min caused 
a cell cycle arrest in all resulting daughters (Fig. S3 A). 
Addition of IAA to parental RPE1 cells shortened the win-
dow of prometaphase tolerance to 60 min (Fig. S3 B). Con-
sequently, we considered 60 min to be the prometaphase 
threshold for IAA-treated cells.
Figure 2. The centriole localization of STIL requires Plk4. (A) Quantifica-
tion of Plk4 protein levels at the centrosome of interphase cells at 24 h after 
addition of the indicated concentrations of IAA (gray bars). The fraction 
of mitotic cells that underwent successful centriole duplication (three or 
more centrioles) was quantified in the same samples (open bars). Bars 
represent the mean of >40 cells from two independent experiments. (B) 
Representative images of Plk4AID/AID cells immunostained with CEP192 and 
Centrin after treatment with the indicated dose of IAA for 24 h. Bars: 
(main) 5 µm; (inset) 1 µm. (C) Quantification of relative protein abundance 
at the centrosome of S or G2 phase (CENP-F positive) cells 1 h after IAA 
addition. Centriole recruitment of STIL requires Plk4. r-SAS6, rabbit SAS6 
antibody; m-SAS6, mouse SAS6 antibody. Bars represent the mean of >35 
cells from two independent experiments. Immunoblot shows no change 
in the level of endogenous STIL after Plk4 degradation. All error bars in 
the figure represent the SEM.
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We next traced the lineage of individual Plk4AID/AID cells 
treated with IAA (Fig. S3 C). Only cells that entered the first 
division within 6 h of IAA addition were considered in our anal-
ysis. As a consequence, the first mitosis nearly always occurred 
with two centrioles at each spindle pole and all daughter cells 
continued to proliferate (Fig. 4, B and C). In subsequent divi-
sions, centriole number was successively reduced as expected 
from failed centriole duplication and continued cell growth. 
48% of daughter cells arrested after the second mitosis, whereas 
78% of daughters arrested after the third mitosis and all daugh-
ter cells arrested after the fourth mitosis (Fig. 4 C). The delayed 
growth arrest after Plk4 destruction strongly suggests that a 
stress associated with a failure of centriole duplication not loss 
of Plk4, per se, is responsible for the proliferative arrest.
In the second division after Plk4 destruction, nearly all 
daughters of mothers that spent >60 min in prometaphase ar-
rested as expected (Fig. 4 D). However, 37% of the daughters 
of mothers that spent <60 min in prometaphase also arrested 
and this fraction increased to 52% and 100% in the third and 
fourth divisions, respectively. It was previously shown that 
continuous inhibition of p38 MAPK activity with the small 
molecule SB203580 overcame the proliferative block caused 
by a prolonged prometaphase induced by transient nocodazole 
treatment. However, inhibition of p38 MAPK activity did not 
prevent or delay the cell cycle arrest caused by Plk4 loss (Fig. 
S3 D). We conclude that the cell cycle arrest caused by centriole 
duplication failure is not simply a result of a prolonged pro-
metaphase duration (Uetake and Sluder, 2010).
Previous work has shown that DNA damage, Hippo path-
way activation, or excessive oxidative stress can cause cell cycle 
arrest (Ganem et al., 2014). However, addition of IAA for 3 d 
did not lead to a detectable increase in DNA damage (measured 
by γH2A.X phosphorylation) or Hippo pathway activation (re-
vealed by LATS2 or YAP phosphorylation) in Plk4AID/AID cells 
(Fig. 4 E). In addition, culturing Plk4AID/AID cells in 3% O2, 
rather than 21% O2, did not prevent the proliferative arrest after 
Plk4 destruction (Fig. 4 F). Collectively, our data suggest that 
DNA damage, Hippo pathway activation, and oxidative stress 
are unlikely to be the cause of the cell cycle arrest that occurs 
after a failure of centriole duplication.
Repression of p53 allows Plk4-depleted 
cells to proliferate and become acentriolar
RPE1 cells maintain a normal p53 response. Plk4AID/AID cells 
but not Plk4+/+ cells showed stabilization of p53 at 2 and 3 d 
after IAA addition (Fig. S4 A). We therefore tested whether 
Figure 3. Plk4 depletion leads to a failure of 
centriole duplication followed by a cell cycle 
arrest. (A) Graph showing the fold increase in 
cell number after IAA addition. Plk4 destruction 
leads to a cell cycle arrest in Plk4AID/AID cells. 
Points show the mean of at least two inde-
pendent experiments performed in triplicate. 
(B) Quantification of the number of Centrin 
foci per cell in interphase at indicated times 
after IAA addition. Bars represent the mean of 
>100 cells from two independent experiments. 
(C) Graph showing the fold increase in cell 
number after IAA washout (WO) and resto-
ration of Plk4 levels. Centriole loss leads to an 
irreversible cell cycle arrest. Points show the 
mean of at least two independent experiments 
performed in triplicate. (D) Quantification of the 
duration of mitosis. Measurements were taken 
over a 24-h period at indicated times after IAA 
addition. Bars represent the mean of >60 cells 
from two independent experiments. (E) Quanti-
fication of relative cell proliferation and fraction 
of cells undergoing chromosome missegrega-
tion or cytokinesis failure. Measurements were 
taken over a 24-h period at indicated times 
after IAA addition. Bars represent the mean of 
>40 cells from two independent experiments. 
(F) Quantification of the frequency of divisions 
resulting in the formation of misshapen nuclei. 
Measurements were taken over a 24-h period 
at indicated times after IAA addition. Bars rep-
resent the mean of >40 cells from two indepen-
dent experiments. All error bars in the figure 
represent the SEM. (G) Selected images from 
a time-lapse series of untreated or IAA-treated 
Plk4AID/AID cells coexpressing histone TagRFP-tu-
bulin, EGFP-Histone H2B, and EGFP-CEP63. In-
sets show EGFP-CEP63 at the centrosome. Time 
is indicated in minutes relative to nuclear enve-
lope breakdown (time point 0). Note that the 
cell treated with IAA for 2 d exhibits an asym-
metric spindle with one acentriolar pole. The in-
terphase nucleus (asterisk) at 189 min later left 
the field of view. Bars: (main) 5 µm; (inset) 1 µm.
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stabilization of p53 contributes to the irreversible cell cycle 
arrest that occurs after Plk4 depletion and centriole duplica-
tion failure. Preventing p53 accumulation using a stably ex-
pressed p53 shRNA (Fig. S4 B) allowed the continued growth 
of cells lacking Plk4 (Fig. 5 A) and led to a partial recovery of 
the clonogenic survival of this population (Fig. S4, C and D). 
Our findings indicate that a failure of centriole duplication 
increases p53 levels, eliciting a p53-dependent cell cycle ar-
rest. This is consistent with prior work showing that knockout 
cells lacking proteins essential for centriole duplication also 
fail to proliferate in the presence of p53 (Bazzi and Anderson, 
2014; Izquierdo et al., 2014).
Plk4AID/AID;p53 shRNA cells proliferated indefinitely in 
the absence of Plk4, and by 6 d after IAA addition Centrin foci 
were undetectable in >90% of cells (Fig. 5, B and C). To con-
firm that chronically treated Plk4AID/AID;p53 shRNA cells lacked 
centrioles, we performed immunostaining for a variety of cen-
triole components (CPAP, SAS6, STIL, CEP135, CEP152, and 
CEP192), but failed to observe centriole foci in the vast major-
ity of cells (unpublished data). We therefore used thin-section 
EM to evaluate the presence of centrioles. Whereas centrioles 
were identified in 37/138 transverse sections of control cells, 
we never observed centrioles in 320 sections from chronically 
IAA-treated cells. Thus, the failure to detect Centrin foci almost 
certainly reflects an absence of centrioles in the vast majority 
of chronically treated Plk4AID/AID;p53 shRNA cells (hereafter 
referred to as acentriolar cells). Consistent with a lack of cen-
trioles, the PCM component γ-tubulin was diffusely localized 
throughout the cytosol of interphase cells lacking centrioles 
and failed to concentrate at acentriolar spindle poles (Fig. 5 C). 
However, 55% of interphase acentriolar cells contained a sin-
gle focus of the PCM component Pericentrin, suggesting that 
Pericentrin may have the capacity to self-organize in the ab-
sence of centrioles (Fig. S4 E).
To directly examine the divisions of cells lacking centri-
oles, acentriolar cells coexpressing TagRFP-tubulin, EGFP-His-
tone H2B, and EGFP-Cep63 were monitored by time-lapse 
microscopy. Untreated Plk4AID/AID;p53 shRNA cells entered 
mitosis with two microtubule asters and assembled robust bipolar 
spindles (Fig. 5 E and Video 3). In contrast, in acentriolar cells, 
microtubule nucleation occurred around the chromatin, before 
self-organizing into a bipolar spindle with Pericentrin, but not 
γ-tubulin, concentrated at the poles (Fig. 5, C and E; Video 4; 
and Fig. S4 E). Acentriolar divisions exhibited an increased 
mitotic duration (mean of 147 min, compared with 42 min for 
untreated cells) and were associated with a higher frequency 
of chromosome segregation errors (40% in acentriolar cells vs. 
17% in control cells) and cytokinesis failure (22% in acentriolar 
cells vs. 1% in control cells) compared with untreated control 
Plk4AID/AID;p53 shRNA cells (Fig. 5 D). Consistent with the 
increased incidence of cytokinesis failure, a subpopulation of 
acentriolar cells contained a tetraploid DNA content (Fig. S4 
F). These mitotic errors are likely to be the cause of the reduced 
growth rate and increased doubling time of acentriolar cells 
(Fig. 5 A and Fig. S4 G). These data are in agreement with 
the view that centrioles are not strictly essential for mitosis in 
vertebrate cells, but increase the fidelity of chromosome segre-
Figure 4. The IAA-induced cell cycle arrest is not caused by a prolonged 
mitosis. (A) Representative images of anaphase cells at indicated times 
after IAA addition. Cells were costained with Centrin and CEP192. Bars: 
(main) 5 µm; (inset) 0.5 µm. (B) Quantification of the percentage of cell 
divisions occurring with the indicated number of centrioles at each spindle 
pole. Measurements were obtained from fixed samples at the indicated 
times after IAA addition. Bars represent the mean of >60 cells from two 
independent experiments. (C) Schematic showing the expected dynamics 
of centriole dilution after IAA treatment. Cells that undergo mitosis within 
6 h of IAA addition almost always contain four centrioles, which dilute out 
as shown in subsequent divisions. (D) Graph showing the prometaphase 
duration and proliferative capacity of IAA-treated Plk4AID/AID cells. Each bar 
represents a daughter cell, its height represents the prometaphase duration 
of the mother cell, and its color represents the fate of the daughter. Only 
cells that underwent their first mitosis within 6 h of IAA treatment were an-
alyzed. The dashed red line indicates the maximum time that IAA-treated 
cells spend in prometaphase before undergoing a cell cycle arrest (Fig. 
S3 D). Data are taken from two independent experiments (n = 199 pro-
metaphases). (E) Immunoblot showing the levels of phosphorylated LATS, 
YAP, and Histone H2AX in IAA-treated Plk4AID/AID and parental RPE1 cells. 
Doxorubicin treatment was used as a control to induce DNA damage. (F) 
Graph showing the fold increase in cell number in IAA-treated Plk4AID/AID 
cells grown in normal (21%) or low (3%) oxygen conditions. Points show 
the mean of two independent experiments performed in triplicate. All error 
bars in the figure represent the SEM.
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gation and cytokinesis (Khodjakov and Rieder, 2001; Debec et 
al., 2010; Sir et al., 2013).
Restoration of endogenous Plk4 levels 
in acentriolar cells results in de novo 
centriole formation
In vertebrate somatic cells, de novo centriole assembly is initi-
ated after the eradication of the existing centrioles by laser ab-
lation or microsurgery (Khodjakov et al., 2002; La Terra et al., 
2005; Uetake et al., 2007). In this case a variable number of de 
novo centrioles are spontaneously generated. We therefore ex-
amined the effect of restoring endogenous Plk4 levels in acen-
triolar cells. Endogenous Plk4 levels returned to normal within 
12 h of IAA washout (Fig. 6 A) and promoted the penetrant 
formation of de novo centrioles: by 2 d after IAA washout, de 
novo centriole assembly occurred in 74% of cells and increased 
to >95% of cells by 4 d after IAA removal (Fig. 6 B and Fig. S4 
H). Knockdown of the cartwheel component STIL prevented 
de novo centriole assembly, suggesting that, similar to canoni-
cal centriole duplication, de novo centrioles assemble through a 
cartwheel-dependent mechanism (Fig. 6 C). Collectively, these 
data show that Plk4 levels are rate limiting for both canonical 
and de novo centriole assembly.
De novo centriole assembly occurred stochastically 
throughout the cytosol of cells, resulting in the formation of a 
variable number of centrioles (Fig. 6 B and Fig. S4 H). Whereas 
cells with one to four de novo centrioles always divided nor-
mally, cells with supernumerary de novo centrioles underwent 
frequent (6–18%) multipolar divisions (Fig. 6, D–F). Because 
the progeny of multipolar divisions are invariably inviable 
(Ganem et al., 2009), aberrant mitotic divisions are likely to 
limit the proliferative potential of cells with supernumerary de 
novo centrioles. The decreased growth potential of cells with 
supernumerary centrioles may explain why the relative fraction 
of cells with a normal centriole number gradually increases in 
abundance after IAA washout (Fig. 6 B).
De novo centriole assembly required cell cycle pro-
gression, as arresting cells in G1 phase with mimosine or the 
CDK2/4 inhibitor PD0332991 greatly reduced the frequency 
of de novo centriole formation by 2 d after IAA washout (Fig. 
S5, A–C; Watson et al., 1991; Fry et al., 2004). To examine the 
composition of de novo centrioles we performed immunostain-
ing for several centriole components at 1, 2, 3, and 4 d after 
Figure 5. Depletion of p53 allows contin-
ued growth in the absence of Plk4. (A) Graph 
showing the fold increase in cell number after 
IAA addition. Points show the mean of at least 
two independent experiments performed in 
triplicate. (B) Quantification of the number of 
Centrin foci per cell in interphase at indicated 
times after IAA addition. Bars represent the 
mean of >150 cells from two independent 
experiments. (C) Selected images of untreated 
control or acentriolar Plk4AID/AID;p53 shRNA 
cells immunostained with α-tubulin, γ-tubulin, 
and Centrin. Bars: (main) 5 µm; (inset) 1 µm. 
(D) Quantification of the duration of mitosis, 
the frequency of divisions resulting in the for-
mation of misshapen nuclei, and the frequency 
of cytokinesis failure and chromosome misseg-
regation in acentriolar Plk4AID/AID;p53 shRNA 
cells. Bars represent the mean of >100 cells 
from two independent experiments. All error 
bars in the figure represent the SEM. (E) Se-
lected images from a time-lapse series of un-
treated control or acentriolar Plk4AID/AID;p53 
shRNA cells coexpressing histone TagRFP-tubu-
lin, EGFP-Histone H2B, and EGFP-CEP63. In-
sets show EGFP-CEP63 at the centrosome. The 
acentriolar cell spends longer in mitosis and 
fails cytokinesis. Time is indicated in minutes 
relative to nuclear envelope breakdown (time 
point 0). Bars: (main) 5 µm; (inset) 1 µm.
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IAA washout. By 2 d after IAA washout, Plk4, CPAP, CEP135, 
CEP152, CEP164, and CEP192 colocalized with at least one 
Centrin-marked, de novo centriole in >75% of cells (Fig. 6 G 
and Fig. S5 D). In contrast, only 40–55% of cells with de novo 
centrioles contained centriole-localized STIL or SAS6, consis-
tent with the fact that STIL and SAS6 are absent from centrioles 
during G1 phase (Strnad et al., 2007; Tang et al., 2011; Arquint 
et al., 2012; Arquint and Nigg, 2014). Importantly, all of the de 
novo centrioles observed in transverse sections by EM exhib-
ited a normal morphology, with triplet microtubules arranged 
with ninefold rotational symmetry (n = 83 total de novo cen-
trioles, 13 of which were sectioned transversely and could be 
assessed for rotational symmetry; Fig. 7, A–B).
To examine the kinetics of de novo centriole assembly, 
we generated acentriolar cells stably expressing EGFP-Cen-
trin and performed time-lapse imaging after IAA washout. 
Approximately 9 h before mitosis, a variable number of 
EGFP-Centrin foci formed dispersed throughout the cytosol 
(Fig. 8, A and B). These foci increased in size and intensity 
until they were indistinguishable from EGFP-Centrin foci 
Figure 6. Restoration of Plk4 levels in acentriolar cells leads to de novo centriole formation. (A) Immunoblot showing the level of immunoprecipitated 
endogenous Plk4-AID-FLAG at the indicated times after IAA washout in acentriolar, Plk4AID/AID;p53 shRNA cells. (B) Quantification of the number of Centrin 
foci per interphase cell at indicated times after IAA washout, in Plk4AID/AID;p53 shRNA cells. Bars represent the mean of >200 cells from three indepen-
dent experiments. (C, top) Quantification of the number of Centrin-marked de novo centrioles in interphase cells at 2 d after IAA washout (WO). Cells 
were transfected with the STIL siRNA 24 h before IAA washout. (bottom) Immunoblot showing depletion of STIL at 48 h after transfection with STIL siRNA. 
(D and E) Quantification of the fraction of bipolar and multipolar divisions in Plk4AID/AID;p53 shRNA at indicated times after IAA washout. Bars represent 
the mean of >120 cells from two independent experiments. All error bars in the figure represent the SEM. (F) Selected images of anaphase phenotypes. 
Both single and pairs of de novo centrioles clustered at the poles of the mitotic spindle. Cells were costained with Centrin and CEP192. (G) Selected im-
ages of Centrin-marked de novo centrioles at 1 d after IAA washout. Cells were costained with Plk4, STIL, SAS6, CPAP, CEP192, CEP152, and CEP135. 
Bars: (main) 5 µm; (inset) 1 µm.
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observed at normal centrioles in control cells. Immunofluo-
rescence staining showed that the newly formed Centrin foci 
colocalized with CEP192 and are thus likely to represent 
de novo centrioles (Fig. 8 C). Once de novo centrioles had 
formed, no additional Centrin foci were generated, consis-
tent with the observation that de novo centriole assembly is 
inhibited by the presence of centrioles (Fig. 8 A and Video 
5; Marshall et al., 2001; La Terra et al., 2005). To test if a 
single centriole is capable of suppressing de novo centriole 
formation, we transiently treated EGFP-Centrin–expressing 
Plk4AID/AID;p53 shRNA cells with IAA to generate a fraction 
of cells with a single centriole, and then removed IAA and 
monitored de novo centriole formation by time-lapse micros-
copy. Strikingly, whereas 80% of acentriolar cells underwent 
de novo centriole formation within 36 h of IAA washout, only 
15% of cells with a single centriole underwent de novo centri-
ole assembly in the same period (Fig. S5 E).
In the first mitotic division after IAA washout, the ma-
jority of single de novo centrioles segregated on the mitotic 
spindle (Fig. 8 D). After the first division, de novo centrioles 
clustered to a single location. Later in the cell cycle, centrioles 
dispersed around the nuclear envelope and underwent dupli-
cation, with each single EGFP-Centrin focus becoming a du-
plex of two centrioles (Fig. 8, A and C; and Video 6). Pairs of 
Centrin foci contained a single focus of the proximal centriole 
marker CNAP1, consistent with an engaged “mother–daughter” 
configuration (Fig. 8 E). CEP164 is a distal appendage pro-
tein that usually marks the mature mother centriole (Graser et 
al., 2007). Surprisingly, however, duplicated pairs of de novo 
centrioles did not always contain a CEP164-positive centriole 
(Fig. S5 F). By 2 d after IAA washout, duplicated centriole 
pairs recruited PCM and acted as MTOCs (Fig. 8 D). We con-
clude that the de novo centrioles are functionally indistinguish-
able from canonical centrioles.
Discussion
In this study, we have developed a chemical genetic approach 
to reversibly deplete Plk4 and centrioles in a proliferating pop-
ulation of human cells. This is the first time the auxin-inducible 
destruction system has been used to reversibly manipulate the 
levels of an endogenous protein in vertebrate cells. In principle, 
the strategy we have taken could be applied to control the levels 
of many proteins that are not amenable to traditional chemical in-
hibition. In the future, combining the AID system with CRISPR/
Cas9 genome engineering will greatly increase the efficiency with 
which biallelic targeting of endogenous genes can be achieved, 
paving the way for rapid and tunable control of protein function.
The long-term consequence of centriole depletion has not 
been studied in a nontransformed vertebrate cell line. By induc-
ing chronic depletion of Plk4, we reveal the presence of a p53-de-
pendent pathway that arrests the growth of untransformed cells 
after a failure of centriole duplication (Fig. 5 A). Furthermore, 
by exploiting the reversibility of Plk4 depletion, we show that 
the cell cycle arrest caused by centriole loss is irreversible (Fig. 
3 C). A recent study arrived at similar conclusions using a potent 
inhibitor of Plk4 kinase activity to deplete centrioles from pro-
liferating cells (Wong et al., 2015). Mouse embryos lacking the 
essential centriole protein CPAP lack centrioles and cilia and die 
during midgestation because of widespread p53-dependent apop-
tosis (Bazzi and Anderson, 2014). Similarly, deletion of CPAP in 
the developing mouse brain also resulted in increased cell death, 
which was rescued by removal of p53 (Insolera et al., 2014). The 
contrast between the apoptotic response in mouse embryos and 
the arrest we observed in human cells suggests that embryonic 
and adult cell types have different proclivities for initiating apop-
tosis or senescence after centriole loss. Interestingly, in contrast 
to the situation in mouse and human cells, Drosophila melano-
Figure 7. De novo formed centrioles have a normal structure. Thin section transmission electron micrographs of existing centrioles (A) or de novo centrioles 
(B) formed 3 d after IAA washout. Bars, 100 nm, unless indicated otherwise.
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gaster cells lacking centrioles do not arrest or die (Basto et al., 
2006; Lecland et al., 2013), suggesting that cell cycle checkpoints 
for eliminating acentriolar cells are more stringent in vertebrates.
Whereas mouse embryos proceed through many cell di-
visions without centrioles before initiating apoptosis, we found 
that many human somatic cells ceased dividing before the total 
loss of centrioles (Fig. 4 B). Importantly, we did not observe de-
tectable increases in Hippo pathway activation, DNA damage, or 
cytokinesis failure in the two to three cell cycles that occur after 
Plk4 degradation (Figs. 3 E and 4 E). We did, however, observe 
an increase in chromosome segregation errors in cells with a 
reduced centriole number (9% at day 1, 19% at day 2, and 14% 
at day 3 after IAA addition; Fig. 3 E). Although chromosome 
segregation errors can lead to a p53-dependent arrest (Thomp-
son and Compton, 2010), the frequency of these errors was too 
low to account for the reduction in proliferation after Plk4 loss 
(Fig. 3 E). In mouse embryos that lack centrioles, the stabilization 
of p53 was proposed to arise as a result of a modest (∼10 min) 
increase in mitotic duration (Bazzi and Anderson, 2014). How-
ever, using single-cell lineage tracing, we show that an extended 
mitosis cannot, by itself, explain the cell cycle arrest that occurs 
in human cells that fail centriole duplication (Fig. 4 D). Further 
investigation will therefore be required to establish the underly-
ing cause of the proliferative arrest that occurs after Plk4 loss.
Figure 8. De novo centrioles recruit PCM and act as MTOCs. (A) Selected images from a time-lapse series showing de novo centriole formation in cells 
expressing histone EGFP-Centrin. De novo centrioles duplicate in the second cycle after they are born. Time is indicated in hours relative to the time of 
IAA washout (time point 0). (B) Quantification of the time of de novo centriole formation relative to the time of cell division. Measurements were made 
using time-lapse movies of EGFP-Centrin expressing cells from two independent experiments. Line represents the mean of >50 cells. (C) Selected images 
illustrating the different configurations adopted by de novo centrioles. Cells were costained with Centrin and CEP192 to identify centrioles. (D) Selected 
images of de novo centrioles in interphase and mitotic cells at 1 and 2 d after IAA washout. The mitotic spindle segregates freestanding de novo centrioles 
in the first division and pairs of replicated centrioles in the second cell division. Cells were costained with α-tubulin, Centrin, and γ-tubulin or Pericentrin. 
(E) Selected images of pairs of de novo centrioles in interphase cells at 2 d after IAA washout. Cells were costained with Centrin, CNAP1, and CEP164. 
Bars: (main) 5 µm; (inset) 1 µm.
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Removal of p53 allowed human cells to proliferate indef-
initely despite the absence of centrioles (Fig. 5 A). As centro-
somes increase the speed of spindle assembly, these acentriolar 
cells formed bipolar spindles at a considerably slower rate than 
cells containing centrioles. In addition, acentriolar cells dis-
played chromosomal instability and frequent cytokinesis failure 
(Fig. 5 D). Similar mitotic errors have been reported in acen-
triolar D. melanogaser cells and transformed vertebrate cell 
lines, highlighting the important role of centrioles in ensuring 
the fidelity of cell division in adult cells (Khodjakov and Rieder, 
2001; Basto et al., 2006; Debec et al., 2010; Sir et al., 2013). 
Surprisingly, however, acentriolar mouse embryos showed no 
detectable increase in chromosome segregation errors (Bazzi 
and Anderson, 2014). The first five rounds of cell division in the 
mouse embryo are naturally acentriolar (Szollosi et al., 1972) and 
it is therefore possible that mouse embryonic divisions are less 
dependent on centrioles for faithful chromosome segregation.
Overexpression of Plk4 did not promote de novo centriole 
formation in acentriolar mouse zygotes (Coelho et al., 2013), 
but was capable of inducing de novo centriole formation in 
unfertilized fly eggs (Peel et al., 2007; Rodrigues-Martins et 
al., 2007) and activated Xenopus laevis oocytes (Eckerdt et al., 
2011). Here we have shown that restoring endogenous levels of 
Plk4 induces de novo centriole formation in acentriolar human 
somatic cells. We speculate that de novo centrioles are created 
from Plk4 foci that form stochastically in the cytosol of acentri-
olar cells (Fig. S5 G). Once these foci surpass a threshold level 
of Plk4 activity, cartwheel assembly would be initiated, leading 
to centriole formation. Consistent with this idea, we were able 
to observe recruitment of the cartwheel components STIL and 
SAS6 to Plk4 foci as an early event occurring before incorpora-
tion of Centrin into de novo centrioles (Fig. S5 G).
De novo centrioles assembled very efficiently (within two 
to three cell cycles) after restoration of Plk4 levels (Fig. 6 B). 
This is in accordance with previous work examining the kinet-
ics of de novo centriole formation in somatic human cells (La 
Terra et al., 2005; Uetake et al., 2007) and green algae (Mar-
shall et al., 2001). Procentrioles formed in S phase are normally 
modified during mitosis to activate their ability to recruit PCM 
and function as MTOCs in the next cell cycle (Wang et al., 
2011). In our experiments, cells that lack centrioles undergo a 
prolonged prometaphase, providing increased time for newly 
created de novo centrioles to be modified and converted into 
MTOCs. Consistently, we observed that in the first cell cycle 
the vast majority of de novo centrioles recruited small amounts 
of PCM in mitosis and were capable of segregating themselves 
on the mitotic spindle (Fig. 8 D). De novo centrioles duplicated 
in the second cell cycle after their creation, consistent with a 
previous study demonstrating that newly formed centrioles 
are modified in mitosis to license their duplication (Fig. 8, 
A and D; Wang et al., 2011).
A single centriole was shown to suppress de novo cen-
triole assembly in the vast majority of cells, supporting the 
conclusion that existing centrioles inhibit the de novo assembly 
pathway (Fig. S5 E; Marshall et al., 2001; La Terra et al., 2005). 
Like canonical centriole assembly, de novo centriole formation 
requires Plk4 activity (Wong et al., 2015). An intriguing possi-
bility, therefore, is that existing centrioles sequester an activator 
of Plk4 and thereby act to inhibit the cytosolic pool of Plk4 
and suppress de novo centriole formation. The ability to induce 
timed de novo centriole biogenesis in populations of cycling 
acentriolar cells offers an excellent tool to dissect the molecular 
events involved in centriole formation and how existing centri-
oles antagonize the de novo pathway.
Materials and methods
Antibody production
A C-terminal Plk4 fragment (aa 510–970) was cloned into a pET-23b 
bacterial expression vector (EMD Millipore) containing a C-termi-
nal 6xHis tag. Recombinant protein was purified from Escherichia 
coli using Ni-NTA beads (QIAGEN) and used for immunization 
(ProSci). A STIL C-terminal peptide VGTFLDVKRLRQLPKLF (aa 
1,271–1,287) was synthesized and conjugated to KLH for immu-
nization. Rabbit immune sera were affinity purified using standard 
procedures. Affinity purified antibodies were directly conjugated to 
DyLight 550 and DyLight 650 fluorophores (Thermo Fisher Scientific) 
for use in immunofluorescence.
Cell culture
hTERT RPE-1 cells were maintained at 37°C in a 5% CO2 atmosphere 
with 21% oxygen. Cells were grown in DMEM/F12 medium containing 
10% fetal bovine serum (Sigma-Aldrich), 0.348% sodium bicarbonate, 
100 U/ml penicillin, 100 U/ml streptomycin, and 2 mM l-glutamine. 
Nocodazole (Sigma-Aldrich) was dissolved in DMSO and used at a 
final concentration of 3.3 µM; Mimosine (Sigma-Aldrich) was dis-
solved in diluted HCl and used at a final concentration of 250 µM; 
PD0332991 (Sigma-Aldrich) was dissolved in DMSO and used at a 
final concentration of 1 µM; SB203580 (Sigma-Aldrich) was dissolved 
in DMSO and used at a final concentration of 10 µM; Doxorubicin 
(Sigma-Aldrich) was dissolved in water and used at a final concentra-
tion of 200 ng/ml; and IAA (Sigma-Aldrich) was dissolved in water 
and used at 500 µM unless otherwise stated.
Gene targeting and stable cell lines
Gene targeting was performed using adeno-associated virus (AAV; Ber-
dougo et al., 2009; Holland et al., 2012b). To generate the Plk4 target-
ing construct we cloned an AID degron followed by a 3xFLAG epitope 
tag, a translational stop codon, the Plk4 3′ UTR, and 150 bp of adjacent 
genomic sequence into the pBluescript derivative pNY to create the 
AID-3xFLAG-3′UTR;loxP-NeoR-loxP vector. 5′ and 3′ homology arms 
were PCR amplified from genomic RPE1 DNA and cloned on either 
side of the central AID-3xFLAG-3′UTR;loxP-NeoR-loxP cassette. The 
entire insert was transferred into the pAAV vector backbone and fully 
sequenced to verify its integrity. hTERT-RPE1 cells were transduced 
with infectious AID-3xFLAG-3′UTR;loxP-NeoR-loxP–containing AAV 
particles. Plk4AID/+ cells were isolated by selection in G418 and resistant 
clones were screened by PCR using primers binding in NeoR and a ge-
nomic sequence adjacent to the targeting construct. A second targeting 
construct was created containing a HA tag in place of the FLAG epitope 
tag and a BlastR in place of NeoR. An additional round of gene targeting 
was performed in Plk4AID/+ cells using AID-HA-3′UTR;loxP-BlastR-
loxP AAV particles. The intergenic position of the NeoR and BlastR cas-
settes reduces the likelihood that their presence will disrupt the function 
of the Plk4 gene. This facilitates the isolation of homozygous targeted al-
leles by allowing concurrent selection for both markers. Plk4AID/AID cells 
were isolated by coselection in G418 and blasticidin and resistant clones 
were screened by PCR using primers that bind in BlastR and a genomic 
sequence adjacent to the targeting construct. Two independent Plk4AID/
AID clones were created and the targeted Plk4-AID-3xFLAG and Plk4-
AID-3xHA alleles were sequenced to verify their integrity. osTIR1-
9xMyc was cloned into the pBabe backbone under the control of the gag 
promoter and introduced into Plk4AID/AID cells using retroviral delivery. 
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Stable integrants were selected in 5 µg/ml puromycin and single clones 
were isolated by limiting dilution. EGFP-tagged Cep63 was cloned 
into the FUGW backbone under the control of the ubiquitin promoter, 
whereas EGFP-tagged histone H2B and TagRFP-tubulin were cloned 
into the FUGW backbone under the control of the CMV promoter. All 
three constructs were introduced into Plk4AID/AID cells using lentiviral de-
livery and single clones were isolated by limiting dilution. A p53 shRNA 
was introduced into cells using lentiviral delivery and single clones were 
isolated using fluorescence-activated cell sorting (Tiscornia et al., 2003).
Antibody techniques
To purify Plk4-AID-3xFLAG, cells were lysed in lysis buffer (10 mM 
Tris, pH 7.5, 0.1% Triton X-100, 100 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 50 mM NaF, 20 mM, β-glycerophosphate, 0.1 mM DTT, 200 nM 
microcystin, 1 mM PMSF, and 1 µM LPC) and sonicated and soluble 
extracts were prepared. The supernatant was incubated with anti-FLAG 
M2 magnetic beads (Sigma-Aldrich). Beads were washed five times in 
lysis buffer and immunopurified protein was analyzed by immunoblot.
For immunoblot analysis, protein samples were separated by SDS-
PAGE, transferred onto nitrocellulose membranes with a Trans-Blot 
Turbo Transfer System (Bio-Rad Laboratories), and then probed with the 
following antibodies: DM1A (mouse anti–α-tubulin, 1:5,000; Sigma-Al-
drich), Plk4 (rabbit, 1:3,200; this study), FLAG M2 (mouse, 1:1,000; 
Sigma-Aldrich), STIL (rabbit, 1:2,500; Bethyl Laboratories, Inc.), Yap 
(rabbit, 1:1,000, Cell Signaling Technology), p-Yap Ser127 (rabbit, 
1:1,000; Cell Signaling Technology), LATS2 (rabbit, 1:1,000; Cell Sig-
naling Technology), p-LATS S1077 (rabbit, 1:500; Yu et al., 2010; a gift 
of D. Pan, Johns Hopkins School of Medicine, Baltimore, MD), and 
p-Histone H2A.X (Ser139; rabbit, 1:1,000; Cell Signaling Technology).
For immunofluorescence, cells were grown on 18-mm glass cov-
erslips and fixed in 100% ice-cold methanol for 10 min. Cells were 
blocked in 2.5% FBS, 200 mM glycine, and 0.1% Triton X-100 in PBS 
for 1 h. Antibody incubations were conducted in the blocking solution 
for 1 h. DNA was detected using DAPI and cells were mounted in Pro-
long Antifade (Invitrogen). Staining was performed with the following 
primary antibodies: GTU-88 (mouse anti–γ-tubulin, 1:250; Abcam), 
Centrin (mouse, 1:1,000; EMD Millipore), CNAP1 (guinea pig, raised 
against the CNAP1 peptide sequence SPTQQDGRGQKNSDAKC, 
1:1,000, a gift from O. Stemmann, University of Bayreuth, Bayreuth, 
Germany), CEP152 (rabbit, 1:5,000; Bethyl Laboratories, Inc.), Plk4-
650 (directly labeled rabbit, 1:1,000; this study), STIL-550 (directly 
labeled rabbit, 1:1,000; this study), CEP135 (rabbit, raised against 
CEP135 aa 695–838, 1:1,000; a gift from A. Hyman, Max Planck In-
stitute for Molecular Cell Biology and Genetics, Dresden, Germany), 
CEP192-Cy3 (directly labeled rabbit, raised against CEP192 aa 1–211, 
1:1,000; a gift from K. Oegema, Ludwig Institute for Cancer Research, 
La Jolla, CA), SAS6-Cy3 (directly labeled rabbit, raised against SAS6 
aa 501–657, 1:1,000, a gift from K. Oegema), SAS6 (mouse, 1:1,000; 
Santa Cruz Biotechnology, Inc.), CPAP-Cy3 (directly labeled rab-
bit, 1:1,000; a gift from K. Oegema), CENP-F (sheep, raised against 
CENP-F aa 1,363–1,640, 1:1,000; a gift from S. Taylor, University of 
Manchester, Manchester, UK), HA (rat anti-HA High Affinity, 1:200; 
Roche), and FLAG (mouse anti-FLAG M2, 1:1,000; Sigma-Aldrich). 
Secondary donkey antibodies were conjugated to Alexa Fluor 488, 555, 
or 650 (Life Technologies). To mark S phase, cells were pulsed with 
EdU before fixation in 100% ice-cold methanol at −20°C for 10 min. 
Cells were washed three times with 0.1% Triton X-100 in PBS and 
stained using a Click-It EdU Alexa Fluor 555 imaging kit (Life Tech-
nologies) according to the manufacturer’s recommendations.
For the cell cycle analysis of Plk4 levels shown in Fig. 1 E, 
cells were pulsed with EdU for 1 h before fixation in 100% ice-cold 
methanol at −20°C for 10 min. Cells were washed three times with 
0.1% Triton X-100, stained using a Click-It EdU Alexa Fluor 555 
imaging kit (Life Technologies), and blocked in 2.5% FBS, 200 mM 
glycine, and 0.1% Triton X-100 in PBS for 1 h. Immunofluorescence 
microscopy was performed using the following antibodies: CENP-F 
(sheep, raised against CENP-F aa 1,363–1,640, 1:1,000; a gift from 
S. Taylor), GTU-88 (mouse anti–γ-tubulin, 1:250; Abcam), and Plk4-
650 (directly labeled rabbit, 1:1,000; this study). G1 phase cells were 
classified as CENP-F and EdU negative, S phase cells were classified 
as EdU positive, and G2 phase cells were classified as CENP-F posi-
tive and EdU negative. The γ-tubulin staining was used to define the 
position of the centrosome.
Immunofluorescence images were collected using a Deltavision 
Elite system (GE Healthcare) controlling a camera (pco.edge 5.5; Sci-
entific CMOS). Acquisition parameters were controlled by SoftWoRx 
suite (GE Healthcare). Images were collected at room temperature 
(25°C) using a 40× 1.35 NA, 60× 1.42 NA, or 100× 1.4 NA oil objec-
tive (Olympus) at 0.2-µm z-sections and subsequently deconvolved in 
SoftWoRx suite. Images were acquired using immersion oil (n = 1.516; 
Applied Precision). For quantitation of signal intensity at the centro-
some, deconvolved 2D maximum intensity projections were saved as 
16-bit TIFF images. Signal intensity was determined using ImageJ by 
drawing a circular region of interest (ROI) around the centriole (ROI 
S). A larger concentric circle (ROI L) was drawn around ROI S. ROI S 
and L were transferred to the channel of interest and the signal in ROI 
S was calculated using the formula IS − [(IL − IS/AL − AS) × AS], 
where A is area and I is integrated pixel intensity.
Live-cell microscopy
Cells were seeded into four-chamber, 35-mm glass bottom culture 
dishes (Greiner) and maintained at 37°C in an environmental control 
station. Images were collected using a Deltavision Elite system con-
trolling a camera (pco.edge 5.5.). Images were acquired with a 40× 
1.35 NA oil lens using immersion oil (n = 1.526). Every 5 min, 7 × 
3-µm z-sections were acquired for EGFP and RFP and maximum inten-
sity projection was created using SoftWoRx. Alternatively, cells were 
imaged using a 40× 1.4 NA Plan Apochromat oil-immersion objective 
(Carl Zeiss) on a confocal microscope (LSM 780; Carl Zeiss) equipped 
with a solid-state 488- and 514-nm laser and a spectral GaAsP detector. 
Images were acquired using immersion oil (n = 1.518; Carl Zeiss). Ac-
quisition parameters, shutters, and focus were controlled by ZEN black 
software (Carl Zeiss). 15 × 1.6-µm z-sections were acquired simultane-
ously for EGFP and/or RFP at 5- or 10-min time intervals. Maximum 
intensity projections were created using ZEN black. Movies were as-
sembled and analyzed using FIJI.
Lineage tracing
For nocodazole treatment, coverslips were assembled into observation 
chambers with medium containing 0.08 µM nocodazole and fields 
of cells were continuously followed by video time-lapse microscopy 
at 37°C for 6 h. After 6 h, the field of view was marked with a dia-
mond scribe; the bottom of the observation chamber was removed and 
washed out with fresh medium several times before being reassembled 
with fresh medium as previously described (Uetake and Sluder, 2012). 
The previously marked fields were continuously followed for at least 
96 h. Lineage tracing of individual cells was performed as previously 
described (Uetake et al., 2007). For IAA and SB203580 treatment, 
cells were exposed to the drug for the duration of imaging. Images 
were collected using a microscope (DMRXE; Leica) equipped with 
phase-contrast optics and a 10× 0.3 NA objective (Leica). Images were 
captured with an Orca ER (Hamamatsu Photonics) camera using HCT 
software (Hamamatsu Photonics) and exported as AVI movies to be 
viewed with QuickTime (Apple).
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Cells were grown on 35-mm Nunclon Delta–treated culture dishes 
(Thermo Fisher Scientific) and fixed (2.5% glutaraldehyde, 3 mM 
MgCl2, and 0.1 M sodium cacodylate, pH 7.2) for 1 h at room tempera-
ture. Cells were rinsed with 0.1 M sodium cacodylate and post-fixed 
with 0.5% OsO4 for 1 h on ice. After a dH2O rinse, plates were stained 
with 0.1% tannic acid, rinsed twice with dH2O, and stained en bloc with 
2% aqueous uranyl acetate. Samples were dehydrated in a graded series 
of ethanol, embedded in Eponate 12 resin (Ted Pella), and polymerized 
at 60°C overnight. Ultrathin 60-nm sections were cut, mounted, and 
stained with 1% tannic acid, followed by 2% uranyl acetate and lead 
citrate. Images were acquired using a transmission electron microscope 
(7600; Hitachi) equipped with a charge coupled device 2,080 × 2,048-
pixel camera (Advanced Microscopy Techniques).
Cell biology
To prepare cells for flow cytometry, cell pellets were fixed in cold 70% 
EtOH for 24 h, washed once in PBS, and resuspended in PBS sup-
plemented with 0.5 mg/ml RNase A and 50 mg/ml propidium iodide. 
Samples were incubated at room temperature for 30 min and analyzed 
on a flow cytometer (FACSCalibur; BD). For RNA interference, 2 × 
105 cells were seeded in a 6-well plate and duplexed siRNAs were 
introduced using RNAiMax (Life Technologies). siRNA directed 
against STIL (5′-GCUCCAAACAGUUUCUGCUGGAAU-3′) was 
purchased from GE Healthcare.
Online supplemental material
Fig. S1 shows the strategy for the generation of Plk4AID/AID cells and 
that Plk4 destruction occurs rapidly in an osTIR1-dependent manner. 
Fig. S2 shows that Plk4 destruction dramatically reduces clonogenic 
survival and that treatment of parental RPE1 cells with IAA does not 
alter mitotic timing. Fig. S3 shows that Plk4AID/AID cells have a window 
of prometaphase tolerance of 97 min, that IAA treatment reduces the 
window of hTERT RPE1 cells to 60 min, and that inhibition of p38 
MAPK activity with SB203580 does not prevent the cell cycle arrest 
that occurs as a result of centriole duplication failure. Fig. S4 shows 
that p53 is stabilized after Plk4 destruction, that depletion of p53 par-
tially rescues the clonogenic survival of cells lacking Plk4, that mitotic 
spindles form in the absence of centrioles, and that the incidence of 
polyploidy increases in acentriolar cells. Fig. S5 shows that de novo 
centrioles do not form in G1-arrested cells, that the composition of de 
novo centrioles is similar at 1–4 d after their assembly, and that a single 
existing centriole is capable of suppressing de novo centriole forma-
tion. Video 1 shows a normal cell division in an untreated Plk4AID/AID 
cell. Video 2 shows an IAA-treated Plk4AID/AID cell dividing with an 
asymmetric spindle. Video 3 shows a normal cell division in an un-
treated Plk4AID/AID;p53 shRNA cell. Video 4 shows a Plk4AID/AID;p53 
shRNA cell dividing without centrioles. Video 5 shows de novo centri-
ole formation after recovery of Plk4 levels. Video 6 shows duplication 
of de novo formed centrioles. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201502089/DC1.
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